Please ensure Javascript is enabled for purposes of website accessibility

Why The Trade Desk, Noodles & Co., and Regeneron Pharmaceuticals Jumped Today

By Dan Caplinger – May 11, 2018 at 3:36PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out which of these companies had strong earnings.

The stock market finished mixed on Friday, with the Dow Jones Industrial Average gaining ground even as some broader benchmarks finished closer to unchanged for the day. In the absence of major news, investors seemed content to let positive trends from earlier in the week continue to play out, anticipating a favorable end to the first-quarter earnings season and hoping for more progress on the macroeconomic and geopolitical fronts to defuse potential controversies. Some good reports from several corners of the market also helped lift sentiment. The Trade Desk (TTD -1.73%), Noodles & Co. (NDLS -1.05%), and Regeneron Pharmaceuticals (REGN -0.43%) were among the best performers on the day. Here's why they did so well.

The Trade Desk puts a good spin on its quarter

Shares of The Trade Desk soared more than 43% after the company reported first-quarter earnings. The provider of programmatic advertising services said that its revenue was higher by more than 60% compared to the year-earlier quarter, with adjusted earnings almost doubling from year-ago levels. Dramatic growth in mobile ads, including mobile video and in-app spending, helped lift the company, as did audio and television ad spending. Trade Desk expects to sustain that momentum for the remainder of the year, boosting its guidance for 2018 as a whole. With its fingers on the pulse of the advertising revenue that drives the business models of the majority of companies on the internet, Trade Desk has plenty of opportunity to keep growing.

Blue and white share certificate for the Trade Desk.

Image source: The Trade Desk.

Noodles: Best served hot

Noodles & Company stock jumped 15% in the wake of the company's first-quarter financial results. The restaurant chain said that revenue fell 5%, with the year-ago decision to close 55 locations having weighed on top-line performance. Comparable-restaurant sales were down a more modest 0.2%, and adjusted net loss per share narrowed by half compared to the first quarter of 2017. Executives believe that the strategic initiatives that the noodle-focused chain has implemented will keep generating positive results toward a full turnaround. Investors have started believing in Noodles again, and if the restaurant chain can get back to positive comps for the full year, it will mark a key victory for Noodles shareholders going forward.

Has Regeneron hit bottom?

Finally, shares of Regeneron Pharmaceuticals climbed 6%. The biotech company has been in the doldrums for nearly a year now, falling more than 40% just since last August, and pressure on the biotech industry more broadly has weighed on Regeneron. Yet today's move seems like a justified bounce, and those who are bullish on the stock point to potential success from key prospects like Dupixent, which is currently approved for atopic dermatitis treatment and could see indications expand to asthma patients as well. Even after the drop, Regeneron shares are far from cheap, but those who still see plenty of healthy growth might find current the stock price a bit easier to swallow than loftier levels in past years.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends The Trade Desk. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Regeneron Pharmaceuticals, Inc. Stock Quote
Regeneron Pharmaceuticals, Inc.
$688.87 (-0.43%) $-2.95
Noodles & Company Stock Quote
Noodles & Company
$4.70 (-1.05%) $0.05
The Trade Desk Stock Quote
The Trade Desk
$59.75 (-1.73%) $-1.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.